Twitter | Search | |
Search Refresh
YaleCCEH Jan 11
This is the new twitter account for the Yale Cooperative Center of Excellence in Hematology. Follow us for news and updates! Retweet and share with your colleagues.
Reply Retweet Like
YaleCCEH Jan 11
Spatial confinement downsizes the inflammatory response of macrophages. Research facilitated by the
Reply Retweet Like
OpenCME Hematology 9h
New CME: Summarize the prognostic implications and treatment considerations for idiopathic cytopenia of undetermined significance, clonal hematopoiesis of indeterminate potential, and clonal cytopenias of undetermined significance.
Reply Retweet Like
Ivy Scthiue (literary) 23h
“Iron overload is/er like blowtorch for fast localised heating.” “Apron railroad his/her spike march or cast commercialised seating.”
Reply Retweet Like
Angkor Hospital Jan 13
AHC is able to offer quality cancer care because of partnerships with organizations like . ASH builds capacity in developing countries through initiatives like their Visitor Training Program (VTP). Learn more about the program:
Reply Retweet Like
YaleCCEH Jan 17
"A VISION for epigenomics in hematopoietic gene regulation". Watch distinguished hematologist Dr. Ross Hardison's talk at :
Reply Retweet Like
EMJ Hematology Jan 16
Potential seen for tailoring treatment for acute myeloid leukemia
Reply Retweet Like
Non🌿 Jan 14
Reply Retweet Like
CU Cancer Center 12h
Congratulations to Dr. Pollyea, recipient of the Robert H. Allen Endowed Chair in Hematology Research, and Dr. Pietras, recipient of the Cleo Meador/George Ryland Scott Endowed Chair in Research!
Reply Retweet Like
OpenCME Hematology 10h
New CME: Review CAR design and CD19 CAR experience, as well as AML CAR target identification challenges.
Reply Retweet Like
OpenCME Hematology 8h
New CME: Review the genomic landscape in MDS/MPN overlap and how mutations influence diagnosis, prognosis and treatment decisions.
Reply Retweet Like
OpenCME Hematology 8h
New CME: Provide an in-depth overview of the efficacy and side effects of combination therapies for acute myeloid leukemia.
Reply Retweet Like
OpenCME Hematology 10h
New CME: Step into (Dark) Liquid: PNH
Reply Retweet Like
YaleCCEH 19h
The beautiful paper "Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis" includes work done .
Reply Retweet Like
MedCram 7h
A concise & effective review of the most important concepts. More clarity in less time with :
Reply Retweet Like
TractManager, Inc. 12h
Is Hematology Automation Primed for a Change? With Bloodhound technology all the hematology workflow steps are unified into one integrated workflow. Read more here:
Reply Retweet Like
YaleCCEH Jan 12
Are you an investigator studying benign ? If so, you can apply to be a Visiting Scientist to Yale!
Reply Retweet Like
Targeted Oncology 17h
Dr. Hobbs at discussed some of the ongoing clinical trials for myelofibrosis: She also told us about some recent advances in the treatment of MF and other MPNs.
Reply Retweet Like
นุ่นจ๊ะ Jan 15
My article 'Comparison of gene expression profiles between human erythroid cells derived from fetal liver and adult peripheral blood' was one of the top 5 most viewed articles published in journal in 2018! 😊
Reply Retweet Like
The ASCO Post 16h
Julie Vose, MD, MBA, and Loretta J. Nastoupil, MD, on Large B-Cell Lymphoma: Real-World Experience With CAR T-Cell Therapy
Reply Retweet Like